Zymergen Inc.’s $4 Billion Initial Public Offering

Freshfields served as issuer’s counsel to Zymergen Inc.

The IPO values the company in excess of $4 billion. The company sold $575 million of shares of common stock, including all shares subject to the underwriters’ greenshoe option, in the offering which closed on April 26, 2021.

Zymergen, a San Francisco Bay Area-based biofacturing company, is a client of Freshfields on a spectrum of capital markets, corporate, compensation and benefits, M&A, joint venture, licensing, IP, tax and regulatory matters. 

The company uses a combination of software, biology, chemistry and automation to develop and manufacture bio-based breakthrough products and materials that deliver value to customers in a broad range of industries.  

The Freshfields team was led by corporate partners Sarah Solum (Picture) and Pamela Marcogliese, associates Sherrie Quinn and Max Neumann, and law clerks Joyce Yeo and Salman Almutawa and senior corporate paralegal Sangeetha Rao, as well as by corporate partner Ethan Klingsberg, litigation partner Boris Feldman, counsel Elizabeth Bieber and associates Lucy Lei and Victor Ma. Employee benefits partner Maj Vaseghi and senior associate Sarah Ghulamhussain led on all executive compensation and equity award plan matters. Tech transactions and data privacy partner Menachem Kaplan, special counsel Peter Jaffe and associate Marissa Yu handled IP and privacy matters. Tax advice was provided by partner Robert Scarborough and counsel Dennis Caracristi. CFIUS and trade compliance advice was provided by partners Aimen Mir and Nabeel Yousef and associate Amy Cattle. The lawyers involved span the Silicon Valley, New York and Washington, DC offices of the firm.  
 

Involved fees earner: Elizabeth Bieber – Freshfields Bruckhaus Deringer LLP; Dennis Caracristi – Freshfields Bruckhaus Deringer LLP; Amy Cattle – Freshfields Bruckhaus Deringer LLP; Boris Feldman – Freshfields Bruckhaus Deringer LLP; Sarah Ghulamhussain – Freshfields Bruckhaus Deringer LLP; Peter Jaffe – Freshfields Bruckhaus Deringer LLP; Menachem Kaplan – Freshfields Bruckhaus Deringer LLP; Ethan Klingsberg – Freshfields Bruckhaus Deringer LLP; Lucy Lei – Freshfields Bruckhaus Deringer LLP; Pamela Marcogliese – Freshfields Bruckhaus Deringer LLP; Aimen Mir – Freshfields Bruckhaus Deringer LLP; Max Neumann – Freshfields Bruckhaus Deringer LLP; Sherrie Quinn – Freshfields Bruckhaus Deringer LLP; Robert Scarborough – Freshfields Bruckhaus Deringer LLP; Sarah Solum – Freshfields Bruckhaus Deringer LLP; Maj Vaseghi – Freshfields Bruckhaus Deringer LLP; Nabeel Yousef – Freshfields Bruckhaus Deringer LLP; Marissa Yu – Freshfields Bruckhaus Deringer LLP;

Law Firms: Freshfields Bruckhaus Deringer LLP;

Clients: Zymergen Inc.;

Author: Martina Bellini